(Diagnosis, Diagnostics, Immunodiagnosis, Immunodiagnostics, Pathogenesis, Vaccines & Drugs)


3996.   Barrett AD. Current status of flavivirus vaccines. Ann N Y Acad Sci  2001 Dec;951:262-71

3997.   Blaney JE Jr, Johnson DH, Firestone CY, Hanson CT, Murphy BR, Whitehead SS. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice. J Virol  2001 Oct;75(20):9731-40

3998.   Chang GJ, Davis BS, Hunt AR, Holmes DA, Kuno G. Flavivirus DNA vaccines: current status and potential. Ann N Y Acad Sci  2001 Dec;951:272-85

3999.   Cuzzubbo AJ, Endy TP, Nisalak A, Kalayanarooj S, Vaughn DW, Ogata SA, Clements DE, Devine PL. Use of recombinant envelope proteins for serological diagnosis of Dengue virus infection in an immunochromatographic assay. Clin Diagn Lab Immunol 2001 Nov;8(6):1150-5

4000.   Gomber S, Ramachandra n V G, Satish Kumar, Agarwal K N, Gupta P, Gupta P, Dewan D K: Hematological observation as diagnostic markers in dengue hemorrhagic fever. Indian Pediat 2001, 38(5), 477-81.(015304). Aug 1, 2001.

4001.   Huang JL, Huang JH, Shyu RH, Teng CW, Lin YL, Kuo MD, Yao CW, Shaio MF. High level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen. J Med Virol  2001 Nov;65(3):553-60

4002.   Openshaw PJ, Culley FJ, Olszewska W. Immunopathogenesis of vaccine-enhanced RSV disease. Vaccine  2001 Oct 15;20 Suppl 1:S27-31

4003.   Pea L, Roda L, Moll F. Desmopressin treatment for a case of dengue hemorrhagic fever/dengue shock syndrome. Clin Infect Dis  2001 Nov 1;33(9):1611-2

4004  Troyer JM, Hanley KA, Whitehead SS, Strickman D, Karron RA, Durbin AP, Murphy BR. A live attenuated recombinant dengue-4 virus vaccine candidate with restricted capacity for dissemination in mosquitoes and lack of transmission from vaccinees to mosquitoes. Am J Trop Med Hyg  2001 Nov;65(5):414-9